Such mechanisms depend on the original metabolic profile of the tumor, including the pattern of expression of NAD+-producing enzymes, such as NAPRT or QPRT, since the latter can come into play for compensating for chronic NAMPT inhibition, ensuring that sufficient NAD+ is produced for a cancer cell to survive. The gene discussed is QPRT; the disease is cancer.